These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 10688818)
21. Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit. Broudy VC; Lin NL; Fox N; Taga T; Saito M; Kaushansky K Blood; 1996 Sep; 88(6):2026-32. PubMed ID: 8822921 [TBL] [Abstract][Full Text] [Related]
23. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood. Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449 [TBL] [Abstract][Full Text] [Related]
24. Three parameters, plasma thrombopoietin levels, plasma glycocalicin levels and megakaryocyte culture, distinguish between different causes of congenital thrombocytopenia. van den Oudenrijn S; Bruin M; Folman CC; Bussel J; de Haas M; von dem Borne AE Br J Haematol; 2002 May; 117(2):390-8. PubMed ID: 11972523 [TBL] [Abstract][Full Text] [Related]
25. Developmental expression of plasminogen activator inhibitor-1 associated with thrombopoietin-dependent megakaryocytic differentiation. Madoiwa S; Komatsu N; Mimuro J; Kimura K; Matsuda M; Sakata Y Blood; 1999 Jul; 94(2):475-82. PubMed ID: 10397715 [TBL] [Abstract][Full Text] [Related]
26. Thrombocytopenia with absent radii (TAR) syndrome: from hemopoietic progenitor to mesenchymal stromal cell disease? Bonsi L; Marchionni C; Alviano F; Lanzoni G; Franchina M; Costa R; Grossi A; Bagnara GP Exp Hematol; 2009 Jan; 37(1):1-7. PubMed ID: 19028006 [TBL] [Abstract][Full Text] [Related]
27. Thrombopoietin: biology and clinical potentials. Miyazaki H; Kato T Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146 [TBL] [Abstract][Full Text] [Related]
28. Hierarchical structure of human megakaryocyte progenitor cells. Hoffman R; Murrav LJ; Young JC; Luens KM; Bruno E Stem Cells; 1996; 14 Suppl 1():75-81. PubMed ID: 11012205 [TBL] [Abstract][Full Text] [Related]
29. Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice. Carver-Moore K; Broxmeyer HE; Luoh SM; Cooper S; Peng J; Burstein SA; Moore MW; de Sauvage FJ Blood; 1996 Aug; 88(3):803-8. PubMed ID: 8704234 [TBL] [Abstract][Full Text] [Related]
30. Effects of cytokines on platelet production from blood and marrow CD34+ cells. Norol F; Vitrat N; Cramer E; Guichard J; Burstein SA; Vainchenker W; Debili N Blood; 1998 Feb; 91(3):830-43. PubMed ID: 9446643 [TBL] [Abstract][Full Text] [Related]
31. [Significance of thrombopoietin and its receptor c-Mpl in regulation of thrombocytopoiesis in thrombocytopenia]. Strauss G; Ballmaier M; Schulze H; Bogenberger J; Riehm H; Welte K Klin Padiatr; 1996; 208(4):168-71. PubMed ID: 8926683 [TBL] [Abstract][Full Text] [Related]
32. Analysis of megakaryocyte growth and development factor (thrombopoietin) effects on blast cell and megakaryocyte growth in myelodysplasia. Fontenay-Roupie M; Dupont JM; Picard F; Fichelson S; Botella A; Melle J; Guesnu M; Casadevall N; Dreyfus F; Bouscary D Leuk Res; 1998 Jun; 22(6):527-35. PubMed ID: 9678719 [TBL] [Abstract][Full Text] [Related]
33. Simultaneous measurement of serum thrombopoietin and expression of megakaryocyte c-Mpl with clinical and laboratory correlates for myelofibrosis with myeloid metaplasia. Elliot MA; Yoon SY; Kao P; Li CY; Tefferi A Eur J Haematol; 2002 Mar; 68(3):175-9. PubMed ID: 12068799 [TBL] [Abstract][Full Text] [Related]
34. Thrombopoietin promotes mixed lineage and megakaryocytic colony-forming cell growth but inhibits primitive and definitive erythropoiesis in cells isolated from early murine yolk sacs. Xie X; Chan RJ; Johnson SA; Starr M; McCarthy J; Kapur R; Yoder MC Blood; 2003 Feb; 101(4):1329-35. PubMed ID: 12393382 [TBL] [Abstract][Full Text] [Related]
36. The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEG rHuMGDF) on megakaryopoiesis in normal subjects and patients with myelodysplasia and acute myeloid leukaemia. Adams JA; Liu Yin JA; Brereton ML; Briggs M; Burgess R; Hyde K Br J Haematol; 1997 Oct; 99(1):139-46. PubMed ID: 9359514 [TBL] [Abstract][Full Text] [Related]
37. Defective megakaryocytopoiesis in the syndrome of thrombocytopenia with absent radii. Homans AC; Cohen JL; Mazur EM Br J Haematol; 1988 Oct; 70(2):205-10. PubMed ID: 3191031 [TBL] [Abstract][Full Text] [Related]
39. The residual megakaryocyte and platelet production in c-mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor. Gainsford T; Nandurkar H; Metcalf D; Robb L; Begley CG; Alexander WS Blood; 2000 Jan; 95(2):528-34. PubMed ID: 10627458 [TBL] [Abstract][Full Text] [Related]
40. Alteration of c-mpl-mediated signal transduction in CD34(+) cells from patients with myelodysplastic syndromes. Kalina U; Hofmann WK; Koschmieder S; Wagner S; Kauschat D; Hoelzer D; Ottmann OG Exp Hematol; 2000 Oct; 28(10):1158-63. PubMed ID: 11027834 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]